FDA Adverse Event
Injury
Summary report: N
OMNI 9
MDR report key: 403254
·
Received July 3, 2002
Report
- Report Number
- 1823260-2002-00209
- Event Type
- Injury
- Date Received
- July 3, 2002
- Date of Event
- June 14, 2002
- Report Date
- June 14, 2002
- Manufacturer
- AVL GMBH
- Product Code
- CEM
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- RESPIRATORY THERAPIST
Narratives
Description of Event or Problem · 1
IN 2002 AT 16:34 PATIENT SAMPLE RUN ON SUSPECT DEVICE AND K+ (POTASSIUM) MEASURED 5.0 MMOL/L. THE FOLLOWING DAY AT 00:29 ANOTHER SAMPLE RAN ON SUSPECT DEVICE AND K+ (POTASSIUM) WAS 9.9 MMOL/L. PATIENT TREATED WITH KAYEXALATE 500 MG. THE SAME DAY AT 5:00 PATIENT SAMPLE RAN ON ANOTHER DEVICE AND 5.7 MMOL/L. PHYSICIAN DISCONTINUED TREATMENT. THE PATIENT WAS TAKEN OFF OF LIFE SUPPORT AND LATER EXPIRED FROM ORGAN FAILURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OMNI 9 | MODULAR CRITICAL CARE ANALYZER | CEM | AVL GMBH | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 2 DAY | Required Intervention |